EFFICACY AND SAFETY OF DIMETHINDENE MALEATE IN CLINICAL PRACTICE



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This review is devoted to analyses of data on efficacy and safety of dimethindene maleate in clinical practice.

Full Text

Restricted Access

About the authors

E S Fedenko

Institute of Immunology

Moscow, Russia

O G Elisyutina

Institute of Immunology

Email: el-olga@yandex.ru
Moscow, Russia

N I Ilina

Institute of Immunology

Moscow, Russia

References

  1. Адо А.Д. Общая аллергология. M., «Медицина». 1978, 463 с.
  2. Гущин И.С. Спонтанная («конститутивная») активность и обратный агонизм на Н1-рецепторах. Рос. Аллергол. Журн. 2006, № 2, с. 3-14.
  3. Гущин И.С. Обратные агонисты Н1-рецепторов как перспективные противоаллергические средства (обзор). Хим.-фарм. журнал. 2010, т. 44, № 1, с. 82-88.
  4. Church M., Church D. Pharmacology of antihistamines. Indian. J. Dermatol. 2013, v. 58, p. 219-224.
  5. Takeshita K., Sakai K., Bacon K.B., Gantner F. Critical role of histamine H4-receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J. Pharmacol. Exp. Ther. 2003, v. 307 (3), p. 1072-1078.
  6. Barrett W.E., Huebner C.F., Rutledge R.A et al. A pharmacologic investigation of dimethpyrindene maleate (Forhistal). Toxicol. Appl. Pharmacol. 1961, v. 3, p. 534-544.
  7. Bhatt A.D., Vaidya A.B., Sane S.P et al. Comparative effect of dimethindene maleate and chlorpheniramine maleate on histamine-induced weal and flare. J. Int. Med. Res. 1991, v. 19 (6), p. 479-483.
  8. Arnera V., Wermeille M., Wellman M. et al. Pharmacokinetics of dimetindene after intravenous and oral administration to healthy volunteers. Arzneimittelforschung. 1990, v. 40 (12), p. 1346-1348.
  9. Rehn D., Geissier H., Schuster O. Effect time-course of the inhibition of histamine induced skin reactions by orally applied dimethindene maleate. Agents Actions. 1991, v. 33 (1-2), p. 221-224.
  10. Добмейер Т. Актуальность и опыт более чем 40 летнего применения диметиндена малеата. Обзор проведенных клинических исследований. Врач. 2012, № 4, с. 51-54.
  11. Horak F., Jäger S., Berger U., Toth J. et al. Controlled exposure to mite allergen for a dose-finding of dimethindene maleate (DMM). Agents Actions. 1994, v. 41, p. 124-126.
  12. Horak F.F., Jäger S., Nirnberger G. et al. Dose-related control of allergic rhinitis symptoms by a Н1-receptor antagonist. Finding the proper doses [correction of dosis] of dimethindene maleate in patients with allergic rhinitis. Int. Arch. Allergy Immunol. 1994, v. 103 (3), p. 298-302.
  13. Englisch W., Bauer C.P. Dimethindene maleate in the treatment of pruritus caused by varizella zoster virus infection in children. Arzneimittelforschung. 1997, v. 47 (11), p. 1233-1235.
  14. Grundmann S.A., Stander S., Luger T. Antihistamine combination treatment for solar urticaria. British Journal of Dermatology. 2008, v. 158, p. 1371-1401.
  15. Schaffler K., Wauschkuhn C.H., Martinelli M. et al. Influences of dimethindene maleate in a new formulation on oculo and psychomotor performance using the oculodynamic test (ODT) in volunteers. Agents Actions. 1994, v. 41, p. 136-137.
  16. Kirchhoff C.H., Kremer B., Haaf-von Below S. et al. Effects of dimethindene maleate nasal spray on the quality of life in seasonal allergic rhinitis. Rhinology. 2003, v. 41, p. 159-166.
  17. Mikó P. Prescription and safety of dimethindene maleate micropellet capsules in Hungary. Orv. Hetil. 2004, v. 145 (7), p. 327-329.
  18. Thomas J.W., Kelly F.R. Клиническое исследование антигистаминного препарата диметиндена (Фенистил) при лечении разных аллергических реакций. Перинатология и педиатрия. 2012, № 4, c. 77-79.
  19. Borici-Mazi R., Kouridakis S., Kontou-Fili K. Cutaneous responses to substance P and calcitonin gene-related peptide in chronic urticaria: the effect of cetirizine and dimethindene. Allergy. 1999, v. 54 (1), p. 46-56.
  20. Matsumoto Y., Miyazato M., Furuta A. et al. Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats. Urology. 2010, v. 75 (4), p. 862-867.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2013



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies